Tuesday February 9 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

Santhera Tel. Pages on BioPortfolio:

BioPortfolio - Food Science Australia - Profile
Tel: +61 2 9490 8333. Fax: +61 2 9490 8499. Email: FSAcontact@csiro.au .... Santhera Presents New Data on MC-4R Antagonist Program for Treatment of Cancer
...
http://www.bioportfolio.com/biocorporate/4174-Food%2525252BS...

Results from other life science and pharmaceutical sites:

Santhera Pharmaceuticals - Leber's Hereditary Optic Neuropathy
Patrick Chinnery, Tel. +44 191 222 5101 P.F.Chinnery@newcastle.ac.uk ... Philip Griffiths, Tel. +44 191 282 5447 P.G.Griffiths@ncl.ac.uk ...
http://www.santhera.com/index.php?mid=65&vid=&lang=...

Search Results | Takeda Pharmaceutical Company Limited
TEL: +81-3-3278-2037 FAX: +81-3-3278-2741 http://www.takeda.com/ Financial .... Santhera and Takeda Establish Collaboration to Develop and Market Idebenone ...
http://www.takeda.com/search/?q=friedreich...

Santhera Pharmaceuticals - Friedreich's Ataxia
Santhera Pharmaceutical Holding Ltd. Clinical Trials. Overview · Indications ... PD Dr. Massimo Pandolfo, Tel. +32 2 555 3429 mpandolf@ulb.ac.be ...
http://www.santhera.com/index.php?mid=57&lang=en...

Search Results | Takeda Pharmaceutical Company Limited
TEL: +81-3-3278-2037 FAX: +81-3-3278-2741 http://www.takeda.com/ Financial News ... of FRDA and will be marketed in Europe by Santhera's partner Takeda. ...
http://www.takeda.com/search/?q=emea...

Santhera Pharmaceuticals - Leber's Hereditary Optic Neuropathy
Santhera Pharmaceutical Holding Ltd. Products & Pipeline ... Patrick Chinnery, Tel. +44 191 222 5101 P.F.Chinnery@newcastle.ac.uk. Patrick Yu Wai Man, Tel. ...
http://www.santhera.com/index.php?mid=20&lang=en...

Search Results | Takeda Pharmaceutical Company Limited
TEL: +81-3-3278-2037 FAX: +81-3-3278-2741 http://www.takeda.com/ Financial ... Santhera and Takeda Extend European Marketing Collaboration for SNT-MC17 into
...
http://www.takeda.com/search/?q=collaboration...

The reversed binding of b-phenethylamine inhibitors of DPP-IV: X ...
gon-like peptide-1; GLP-1. *Corresponding author. Tel.: +49 6221 6510146; fax: + 49 6221. 6510111; e-mail: sonja.nordhoff@santhera.com ...
http://www.santhera.com/downloads/Rummey%202006.pdf...

Long-term blinded placebo-controlled study of SNT-MC17/idebenone ...
3Santhera Pharmaceuticals, Liestal, Switzerland ... Tel: Phone: +32 16 34 38 45, Fax: +32 16 34 38 42, Email: gunnar.buyse/at/uzleuven.be ...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2639086/...

In silico fragment-based discovery of DPP-IV S1 pocket binders
Tel.: +49 6221 6510 117; fax: +49 0 6221 6510. 111; e-mail: guenther.metz@ santhera.com. Bioorganic & Medicinal Chemistry Letters 16 (2006) 1405–1409 ...
http://www.santhera.com/downloads/Rummey_BioorgMedChemLett06...

Opsona Appoints new Chairman & Non Executive Director - Latest ...
... Santhera, Inc. (Liestal, Switzerland) and BioXell SpA (, Vice-Chairman; Milano, ... For media quiries please contact: Niamh Lyons Tel:- + 353 1 6633602
...
http://www.opsona.com/index.jsp?p=93&n=98&a=80...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2010 - BioPortfolio Limited.